UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4591) 4591
Book Chapter (109) 109
Newsletter (8) 8
Newspaper Article (7) 7
Magazine Article (5) 5
Dissertation (3) 3
Book / eBook (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4228) 4228
female (4180) 4180
science & technology (3733) 3733
life sciences & biomedicine (3625) 3625
middle aged (2714) 2714
endometrial cancer (2672) 2672
oncology (2377) 2377
aged (2270) 2270
endometrial neoplasms - pathology (1954) 1954
adult (1881) 1881
endometrial neoplasms - mortality (1745) 1745
cancer (1635) 1635
prognosis (1379) 1379
obstetrics & gynecology (1322) 1322
neoplasm staging (1284) 1284
aged, 80 and over (1100) 1100
retrospective studies (1000) 1000
risk factors (970) 970
endometrial neoplasms - surgery (889) 889
survival rate (859) 859
research (588) 588
follow-up studies (581) 581
health aspects (567) 567
endometrial neoplasms - genetics (564) 564
ovarian cancer (547) 547
analysis (522) 522
treatment outcome (511) 511
endometrial neoplasms - epidemiology (507) 507
surgery (502) 502
survival analysis (486) 486
care and treatment (485) 485
obstetrics and gynecology (481) 481
endometrium (473) 473
endometrial neoplasms - therapy (472) 472
hematology, oncology and palliative medicine (448) 448
disease-free survival (436) 436
endometrial carcinoma (432) 432
hysterectomy (431) 431
abridged index medicus (428) 428
endometrial neoplasms - metabolism (413) 413
endometrial neoplasms - diagnosis (410) 410
tumors (380) 380
immunohistochemistry (376) 376
survival (372) 372
chemotherapy (350) 350
neoplasm invasiveness (335) 335
endometrial neoplasms - drug therapy (332) 332
breast cancer (331) 331
pathology (324) 324
carcinoma, endometrioid - pathology (319) 319
lymphatic metastasis (318) 318
cohort studies (313) 313
oncology, experimental (312) 312
medicine & public health (306) 306
combined modality therapy (304) 304
adenocarcinoma - mortality (301) 301
carcinoma, endometrioid - mortality (300) 300
endometrial neoplasms - radiotherapy (300) 300
adenocarcinoma - pathology (299) 299
metastasis (294) 294
women (293) 293
mortality (291) 291
proportional hazards models (291) 291
neoplasm grading (290) 290
male (283) 283
diagnosis (278) 278
incidence (278) 278
gynecology (274) 274
prospective studies (263) 263
genetic aspects (250) 250
medical prognosis (250) 250
case-control studies (249) 249
kaplan-meier estimate (249) 249
patients (249) 249
multivariate analysis (244) 244
ovarian neoplasms - pathology (243) 243
health risk assessment (242) 242
body mass index (240) 240
neoplasm recurrence, local - pathology (238) 238
time factors (237) 237
lymph node excision (236) 236
epidemiology (234) 234
cervical cancer (233) 233
gene expression (232) 232
age factors (231) 231
development and progression (231) 231
mutation (227) 227
young adult (225) 225
ovarian neoplasms - mortality (223) 223
neoplasm recurrence, local - mortality (222) 222
radiotherapy (222) 222
endometrial neoplasms (218) 218
endometrial neoplasms - etiology (218) 218
carcinoma (213) 213
research article (210) 210
risk assessment (208) 208
obesity (207) 207
studies (207) 207
uterine neoplasms - pathology (200) 200
uterine neoplasms - mortality (199) 199
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4608) 4608
Chinese (41) 41
German (40) 40
French (34) 34
Japanese (14) 14
Polish (13) 13
Russian (13) 13
Spanish (11) 11
Italian (10) 10
Portuguese (7) 7
Bulgarian (6) 6
Czech (6) 6
Hungarian (5) 5
Norwegian (5) 5
Korean (3) 3
Danish (2) 2
Romanian (2) 2
Serbian (2) 2
Dutch (1) 1
Hebrew (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, pp. e0145754 - e0145754
Background High-grade serous ovarian and endometrial cancers are the most lethal female reproductive tract malignancies worldwide. In part, failure to treat... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Endometrial Neoplasms - mortality | Humans | Middle Aged | Ovarian Neoplasms - mortality | Genital Neoplasms, Female - drug therapy | DNA, Neoplasm - blood | Endometrial Neoplasms - genetics | Adult | Female | Neoplasm Recurrence, Local - blood | Ovarian Neoplasms - drug therapy | Genital Neoplasms, Female - genetics | CA-125 Antigen - blood | Ovarian Neoplasms - blood | Genital Neoplasms, Female - blood | Mutation - genetics | Breast Neoplasms - drug therapy | Biomarkers, Tumor - blood | Genital Neoplasms, Female - mortality | Exome - genetics | Breast Neoplasms - genetics | Breast Neoplasms - blood | Breast Neoplasms - mortality | Endometrial Neoplasms - drug therapy | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Endometrial Neoplasms - blood | Physiological aspects | Prognosis | Biological markers | Genital cancer | Tumors | Plasma | Scanning | Ovarian carcinoma | Fallopian tube | Cancer therapies | Ovarian cancer | Gene sequencing | Computed tomography | Surgery | Quality | Imaging | Endometrium | Deoxyribonucleic acid--DNA | DNA probes | Gynecology | Breast cancer | Patients | Survival | Obstetrics | Medicine | Lead time | Chemotherapy | Surveillance | Womens health | Biomarkers | Diagnostic systems | Mutation | Reproductive system | Uterine cancer | Peritoneum | Cancer | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2015, Volume 33, Issue 34, pp. 4015 - 4022
Journal Article
Clinical cancer research, ISSN 1557-3265, 08/2013, Volume 19, Issue 18, pp. 5227 - 5239
Purpose: The aim of this study was to identify and validate novel predictive and/or prognostic serum proteomic biomarkers in patients with epithelial ovarian... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Endometrial Neoplasms - mortality | Peritoneal Neoplasms - blood | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Ovarian Neoplasms - mortality | Adenocarcinoma, Clear Cell - blood | Cystadenocarcinoma, Serous - drug therapy | Bevacizumab | Patient Selection | Fallopian Tube Neoplasms - blood | Peritoneal Neoplasms - drug therapy | Adenocarcinoma, Mucinous - blood | Angiogenesis Inhibitors - therapeutic use | Chromatography, Liquid | Adult | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Cystadenocarcinoma, Serous - blood | Antibodies, Monoclonal, Humanized - therapeutic use | Ovarian Neoplasms - blood | Survival Rate | Peritoneal Neoplasms - mortality | Biomarkers, Tumor - blood | Adenocarcinoma, Mucinous - mortality | Validation Studies as Topic | Fallopian Tube Neoplasms - mortality | Cystadenocarcinoma, Serous - mortality | Endometrial Neoplasms - drug therapy | Aged | Neoplasm Staging | Endometrial Neoplasms - blood | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Index Medicus | bevacizumab | predictive | ICON7 | proteomics | serum | biomarkers
Journal Article
Gut, ISSN 0017-5749, 03/2017, Volume 66, Issue 3, pp. 464 - 472
ObjectiveEstimates of cancer risk and the effects of surveillance in Lynch syndrome have been subject to bias, partly through reliance on retrospective... 
MSH2 MUTATION | IMPACT | MANAGEMENT | NONPOLYPOSIS COLORECTAL-CANCER | MUTATION CARRIERS | FAMILIES | GUIDELINES | RISK | MISMATCH REPAIR | ADENOMAS | Cancer genetics | cancer syndromes | colorectal cancer | cancer prevention | colonoscopy | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Prospective Studies | Age Factors | Endometrial Neoplasms - mortality | Humans | Middle Aged | Male | Ovarian Neoplasms - mortality | Incidence | Colorectal Neoplasms, Hereditary Nonpolyposis - diagnostic imaging | Young Adult | Colorectal Neoplasms, Hereditary Nonpolyposis - mortality | Colonoscopy | Aged, 80 and over | Adult | Female | Child | Databases, Factual | Gene Expression | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Survival Rate | MutS Homolog 2 Protein - genetics | Endometrial Neoplasms - epidemiology | DNA-Binding Proteins - genetics | Ovarian Neoplasms - epidemiology | Colorectal Neoplasms, Hereditary Nonpolyposis - epidemiology | MutL Protein Homolog 1 - genetics | Adolescent | Heterozygote | Aged | Mismatch Repair Endonuclease PMS2 - genetics | Population Surveillance | Cancer patients | Research | Gene mutations | Health aspects | Colorectal cancer | Index Medicus | Abridged Index Medicus | CANCER SYNDROMES | COLONOSCOPY | CANCER GENETICS | COLORECTAL CANCER | Colon | CANCER PREVENTION | 1506
Journal Article
Journal Article
Annals of surgical oncology, ISSN 1068-9265, 1/2011, Volume 18, Issue 1, pp. 49 - 57
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 12, pp. 1554 - 1561
Journal Article
Annals of surgical oncology, ISSN 1534-4681, 11/2011, Volume 19, Issue 6, pp. 1966 - 1972
Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are measures of metabolic activity of tumors determined by fluorine-18 fluorodeoxyglucose... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | Life Sciences & Biomedicine | Science & Technology | Prognosis | Follow-Up Studies | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Tomography, X-Ray Computed | Positron-Emission Tomography | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Multimodal Imaging | Neoplasm Grading | Adenocarcinoma, Mucinous - surgery | Aged, 80 and over | Adult | Female | Retrospective Studies | Radiopharmaceuticals | Adenocarcinoma, Clear Cell - surgery | Ovarian Neoplasms - diagnosis | Survival Rate | Neoplasm Recurrence, Local - diagnosis | Adenocarcinoma, Clear Cell - diagnosis | Endometrial Neoplasms - diagnosis | Cystadenocarcinoma, Serous - surgery | Adenocarcinoma, Mucinous - mortality | Adenocarcinoma, Mucinous - diagnosis | Endometrial Neoplasms - surgery | Cystadenocarcinoma, Serous - mortality | Glycolysis | Fluorodeoxyglucose F18 | Aged | Cystadenocarcinoma, Serous - diagnosis | Neoplasm Staging | Ovarian Neoplasms - surgery | Medical colleges | Care and treatment | PET imaging | Oncology, Experimental | Research | Fluorides | Ovarian cancer | Pets | Glucose metabolism | Cancer patients | Fluorine compounds | Sport-utility vehicles | Tumors | Cancer | Index Medicus
Journal Article
Cancer epidemiology, biomarkers & prevention, ISSN 1538-7755, 08/2015, Volume 24, Issue 9, pp. 1407 - 1415
Journal Article